Clinical Trial Update: Safety and Immunogenicity of a Paediatric Dose of Virosomal Hepatitis A Vaccine [Phase 2]

View source ↗

Summary

A phase 2 study evaluating the safety and immunogenicity of a pediatric dose of the Virosomal Hepatitis A Vaccine has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis A

Drugs mentioned

• Virosomal Hepatitis A Vaccine (hepatitis A vaccine (virosomal))

Snippet

Sponsor: Crucell Holland BV | Conditions: Hepatitis A | Phase 2 | Status: COMPLETED